Commentary
This meta-analysis by U. Hayat et al. (University of Kansas School of Medicine, USA) summarizes available literature about the protective impact of coffee consumption on NAFLD and liver fibrosis.
This meta-analysis revealed a 23% decreased risk of development of NAFLD among patients who drank coffee regularly; this relationship was found to be statistically significant. Furthermore, in patients who had a previous diagnosis of NAFLD, there was a 32% reduced risk in developing fibrosis in patients who drank coffee daily compared to those who did not.
